| Name: | Azilsartan Impurity C |
| Catalogue No. | VL252012 |
| CAS No. | 1397836-49-5 |
| Molecular Formula | C₂₄H₂₂N₄O₄ |
| Molecular Weight | 430.46 |
| Status | In-stock |
| IUPAC Name | 2-Ethoxy-1-[[2'-[(hydroxyamino)iminomethyl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid; |
| Description | Azilsartan Impurity C (CAS No: 1397836-49-5) or 2-Ethoxy-1-[[2'-[(hydroxyamino)iminomethyl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid, Azilsartan Impurity Cis an impurity of Azilsartan it acts as to binds to AT1 receptors as an antagonist, blocking vasoconstrictor and aldosterone-secreting effects of angiotensin II. it belongs to antihypertensive class. |
| References | Jones, Jocelyn D., et al. “Azilsartan Medoxomil (Edarbi).” Pharmacy and Therapeutics, vol. 36, no. 10, 1 Oct. 2011, pp. 634–640, www.ncbi.nlm.nih.gov/pmc/articles/PMC3278144/. Accessed 28 Jan. 2022. |
